Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Payables (2016 - 2025)

Nephros has reported Payables over the past 16 years, most recently at $914000.0 for Q4 2025.

  • Quarterly results put Payables at $914000.0 for Q4 2025, up 40.83% from a year ago — trailing twelve months through Dec 2025 was $914000.0 (up 40.83% YoY), and the annual figure for FY2025 was $914000.0, up 40.83%.
  • Payables for Q4 2025 was $914000.0 at Nephros, down from $936000.0 in the prior quarter.
  • Over the last five years, Payables for NEPH hit a ceiling of $1.4 million in Q2 2022 and a floor of $302000.0 in Q2 2023.
  • Median Payables over the past 5 years was $792000.0 (2022), compared with a mean of $822750.0.
  • Biggest five-year swings in Payables: plummeted 78.6% in 2023 and later skyrocketed 283.77% in 2024.
  • Nephros' Payables stood at $1.3 million in 2021, then crashed by 44.53% to $740000.0 in 2022, then rose by 17.97% to $873000.0 in 2023, then decreased by 25.66% to $649000.0 in 2024, then skyrocketed by 40.83% to $914000.0 in 2025.
  • The last three reported values for Payables were $914000.0 (Q4 2025), $936000.0 (Q3 2025), and $632000.0 (Q2 2025) per Business Quant data.